Ollie's Bargain Outlet OLLI 深 沪
已收盘 12-12 16:00:00 美东时间
113.91
-2.260
-1.95%
华盛通- 最 高118.605
- 今 开116.69
- 成交量 96.64万股
- 最 低 113.46
- 昨 收 116.17
- 总市值 69.84亿
- 52周最高 141.74
- 市盈率 静 35.22
- 换手率 1.58%
- 52周最低 94.875
- 委 比 46.26%
- 总股本 6131.02万
- 历史最高 141.74
- 量 比 0.44
- 振 幅 4.43%
- 历史最低 14.88
- 每 手 1
- 风险率 11.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
12-12 10:24
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
12-11 10:33
Ollie's Bargain Outlet三季度强劲增长但股价下跌
Ollie‘s Bargain Outlet（OLLI）周二尾盘下跌3.5%，此前该公司报告了第三季度的强劲增长，但其股价却出现下滑。
12-10 04:27
Ollie's Bargain Outlet shares are trading lower after the company reported mixed Q3 results, with sales coming in below estimates.
Ollie's Bargain Outlet shares are trading lower after the company reported mixe...
12-09 20:59
Ollie's Bargain Outlet Raises FY2025 Adj EPS Guidance from $3.76-$3.84 to $3.81-$3.87 vs $3.85 Est; Raises FY2025 Sales Guidance from $2.631B-$2.644B to $2.648B-$2.655B vs $2.644B Est
Outlook The Company is raising its previously provided sales and earnings outlook for fiscal 2025. A comparison of the current and previous outlook figures is contained in the table
12-09 20:05
Earnings Scheduled For December 9, 2025
Companies Reporting Before The Bell • TH International (NASDAQ:THCH) is likely ...
12-09 19:11
A Peek at Ollie's Bargain Outlet's Future Earnings
Ollie's Bargain Outlet (NASDAQ:OLLI) is set to give its latest quarterly earnin...
12-08 22:01
Industry Comparison: Evaluating Amazon.com Against Competitors In Broadline Retail Industry
Amidst today's fast-paced and highly competitive business environment, it is cr...
12-02 23:01
Insights into Macy's's Upcoming Earnings
Macy's (NYSE:M) is gearing up to announce its quarterly earnings on Wednesday, ...
12-02 23:00
美股大行评级 | 超配！BETA、BillionToOne获多家机构首予评级；摩根大通上调阿斯麦目标价升至1275美元
今日重点评级关注：RBC Capital：上调Neumora Therapeutics评级至"跑赢大市"，目标价从4美元升至7美元；HC Wainwright & Co.：维持ProMIS Neurosciences"买入"评级，目标价从4美元升至18美元
12-02 09:50
